Journal of the National Cancer Center
Издатель: Elsevier · ISSN 2667-0054 · 53 статей
- Tumor microenvironment heterogeneity and immunotherapy resistance: multidimensional modulation strategies for precision breakthroughs
- Irreversible electroporation activates the NLRP3 inflammasome pathway mediating the antitumor immune responses in pancreatic cancer
- Comprehensive immunological profiling across diverse clinical and pathological subtypes of lung adenocarcinoma
- Sapogenin-based nanoscale assemblies induce immunogenic cell death, remodel the tumor microenvironment, and drive systemic antitumor immunity in melanoma
- Squamous carcinoma cells drive lipid metabolic reprogramming of macrophages in head and neck squamous cell carcinoma by tunneling nanotube-mediated mitochondrial transfer
- Patient selection for local consolidative therapy in advanced non-small cell lung cancer after first line systemic therapy: a prospective study
- RNF5-DNAJA1 axis dictates selinexor sensitivity of multiple myeloma by regulating mitochondrial unfolded protein response
- Neuronal hijacking of cancer niches: integration, remodeling, evolution
- Comparative efficacy of Chinese-developed versus imported PD-1/PD-L1 inhibitors in first-line combination therapy for advanced NSCLC: a systematic review and network meta-analysis
- Systemic inflammatory protein signatures associated with gastric lesion progression and risk of gastric cancer
- Cancer innervation: from mechanisms to clinical implications
- Global patterns and trends in colon cancer incidence by anatomical subsite in 2022: a population-based study
- CDK13 phosphorylates KDM2A to activate a NUP93–STAT3–HMGCR cascade that promotes PDAC metastasis via cholesterol biosynthesis
- Epstein–Barr virus (EBV)–associated lung carcinoma
- Biological time and occupational leukemogenesis: the circadian rhythm as a cofactor in benzene toxicity
- Accelerating the clinical translation of bioengineered anticancer therapeutics
- Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy
- Technical review of artificial intelligence in TCR-T therapy
- Cytoskeletal dynamics in breast cancer: mechanistic insights and therapeutic opportunities
- Epidemiological characteristics and risk factors of lung cancer in a population with incidental pulmonary nodules in China: a prospective multicenter study of 10,560 cases
- Persistent and widening geographic disparities in liver cancer mortality in China, 1987–2021: a 35-year analysis from a national perspective
- Circulating tumor DNA as a predictive biomarker for prognosis in hepatocellular carcinoma: a systematic review and meta-analysis
- Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses
- Orelabrutinib, fludarabine, cyclophosphamide, and obinutuzumab (OFCG) for first-line treatment of chronic lymphocytic leukemia: a multicenter phase II trial (cwCLL-001 trial)
- Work at night, sleep loss, fatigue, and cancer: exposure, mechanisms, and epidemiological evidence
- Εndogenous metabolomic responses in circadian disrupted night shift working populations: a scoping review
- Association between green tea-based chemoprevention and epithelial–mesenchymal transition: current understanding and future perspectives
- Global variations, temporal trend, and socioeconomic association of early-onset cancer incidence by subtypes: a population-based cancer registry study
- Immunosenescence: unraveling the impact on cancer immunotherapy in the aging population
- Distinct molecular trajectories of size enlargement and solid component development in pulmonary ground-glass nodules: an integrative proteomic and phosphoproteomic analysis